Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology · Published 2026-06-28 · DOI 10.1111/bph.70548

Free full text

Authors (4)

Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ramalingam, A., Köhler, Z., Ferdinandy, P., et al. (2026). Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies. British Journal of Pharmacology. https://doi.org/10.1111/bph.70548

Related articles

• Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study · Cancer Immunology, Immunotherapy · 2025 · Cites or is cited by this article
• Activation of sigma non‐opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive‐like behaviours in mice · British Journal of Pharmacology · 2026 · Same journal
• Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation · British Journal of Pharmacology · 2026 · Same journal
• A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer · British Journal of Pharmacology · 2026 · Same journal
• Serotonin engages divergent 5‐HT receptor pathways for cell type‐resolved modulation of prefrontal layer 5 microcircuits · British Journal of Pharmacology · 2026 · Same journal
• Decoding functional specialization in G protein‐coupled receptors (GPCRs) through evolution‐guided residue profiling · British Journal of Pharmacology · 2026 · Same journal
• Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective · British Journal of Pharmacology · 2026 · Same journal
• Thirty‐day dapagliflozin therapy improves the nanomechanical properties of red blood cells in patients with type 1 diabetes · British Journal of Pharmacology · 2026 · Same journal
• Targeting sphingosine‐1‐phosphate receptor‐2 attenuates spinal cord injury by preventing neuronal ferroptosis · British Journal of Pharmacology · 2026 · Same journal
• Virtual cell construction for artificial intelligence‐driven drug discovery · British Journal of Pharmacology · 2026 · Same journal